Skip to content

Supplier News

Hi-Tech to launch Keppra generic

Hi-Tech Pharmacal Co. has received Food and Drug Administration for levetiracetam oral solution 100mg/ml, an anti-seizure medication. The company said Wednesday that it plans to ship its product, a generic version of UCB Pharma’s Keppra oral solution, by May.

Pfizer buys Emergen-C maker Alacer

Pfizer Inc. has acquired Alacer Corp., the maker and distributor of Emergen-C products, the nation’s largest-selling branded vitamin C product line. Financial terms of the deal, announced Monday, weren’t disclosed.

Mylan’s Mauro tabbed as GPhA chairman

Tony Mauro, president of Mylan North America and its Mylan Pharmaceuticals subsidiary, has been elected as chairman of the Generic Pharmaceutical Association (GPhA) board of directors. Mylan said Friday that Mauro’s term as GPhA chairman will last for one year.

ScarAway Silicone Scar Sheets to hit shelves at Kroger

Mitchell-Vance Laboratories has landed retail distribution for its ScarAway Silicone Scar Sheets with food and drug retail giant Kroger Co. The scar care company said plans call for the product to roll out to all Kroger and Kroger-owned stores nationwide on April 1.

Gorsky to become Johnson & Johnson CEO

Johnson & Johnson has named vice chairman Alex Gorsky as its next chief executive officer, succeeding Bill Weldon. Announcing the move late Tuesday, J&J said Gorsky, 51, is slated to take the CEO reins on April 26 at the company’s annual shareholder meeting.

Kimberly-Clark’s Kotex becomes billion-dollar brand

Kimberly-Clark Corp. now has another billion-dollar brand: Kotex. The company said Monday that Kotex crossed the billion-dollar global net sales mark in 2011, following two consecutive years of significant growth in the feminine care category.

McNeil recalls Tylenol infant oral suspension

McNeil Consumer Healthcare is voluntarily recalling about 574,000 bottles of Infants’ Tylenol Oral Suspension pain reliever/fever reducer, citing concerns about the syringe dosing system. The McNeil-PPC Inc.

Mylan to rename specialty pharmaceuticals unit

Mylan Inc. plans to change the name of its branded specialty pharmaceutical business from Dey Pharma to Mylan Specialty. The company said Wednesday that Dey is conducting business as Mylan Specialty effective immediately, but Dey Pharma L.P.

Kellogg to buy Pringles from Procter & Gamble

Kellogg Co. plans to acquire the Pringles snack business from Procter & Gamble Co. for nearly $2.7 billion. The companies said Wednesday that the all-cash transaction is expected to be finalized this summer, pending regulatory approvals.

Perrigo rolls out store-brand Claritin-D 12

Perrigo Co. has begun shipping Loratadine-D 12-hour extended-release tablets for allergies. The company said Tuesday that its product is the store-brand equivalent to Schering-Plough’s Claritin-D 12-hour extended release tablets.

Merck wins approval for glaucoma treatment

Merck has been cleared by the Food and Drug Administration to market Zioptan 0.0015%, which the company said is the first preservative-free prostaglandin analog ophthalmic solution. The pharmaceutical company said Monday that Zioptan (tafluprost ophthalmic solution 0.

Amylin ships Bydureon in U.S.

Amylin Pharmaceuticals Inc. has released Bydureon, which it called the first and only once-weekly treatment for type 2 diabetes, to U.S. pharmacies.